diltiazem has been researched along with sirolimus in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y; Li, YH; Wang, YH; Yang, L; Yang, SL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chen, H; Daloze, P; Dumont, L; Xu, D | 1 |
| Böttiger, Y; Brattström, C; Burke, JT; Häss, G; Säwe, J; Tollemar, J; Zimmerman, JJ | 1 |
| Brattström, C; Wilczek, HE | 1 |
| Aquilante, CL; Fish, DN; Kiser, TH; Schoeppler, KE; Zamora, MR | 1 |
1 review(s) available for diltiazem and sirolimus
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for diltiazem and sirolimus
| Article | Year |
|---|---|
Pharmacokinetic interaction between single oral doses of diltiazem and sirolimus in healthy volunteers.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Calcium Channel Blockers; Cross-Over Studies; Diltiazem; Drug Administration Schedule; Drug Interactions; Female; Humans; Immunosuppressive Agents; Male; Sirolimus | 2001 |
6 other study(ies) available for diltiazem and sirolimus
| Article | Year |
|---|---|
Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.
Topics: Computational Biology; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Molecular Structure; Principal Component Analysis; Pyrrolizidine Alkaloids; Quantitative Structure-Activity Relationship; Reproducibility of Results; Substrate Specificity; Venlafaxine Hydrochloride | 2005 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interaction of diltiazem and rapamycin on survival of rat cardiac allografts.
Topics: Animals; Diltiazem; Drug Synergism; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Polyenes; Rats; Rats, Inbred Lew; Rats, Inbred WF; Sirolimus; Transplantation, Homologous | 1993 |
Sirolimus experience at a Swedish transplantation center.
Topics: Clinical Trials as Topic; Diltiazem; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Kidney Transplantation; Reference Values; Registries; Sirolimus; Sweden | 2003 |
The impact of genetic polymorphisms, diltiazem, and demographic variables on everolimus trough concentrations in lung transplant recipients.
Topics: Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B; Biomarkers; Cross-Sectional Studies; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP3A; Demography; Diltiazem; Everolimus; Female; Follow-Up Studies; Gene Expression Regulation; Genotype; Humans; Immunosuppressive Agents; Lung Diseases; Lung Transplantation; Male; Middle Aged; Polymorphism, Genetic; Pregnane X Receptor; Prognosis; Receptors, Steroid; Sirolimus; Tissue Distribution; Transplant Recipients; Vasodilator Agents | 2014 |